Skip to Main Content

Axogen, Inc. Common Stock

AXGN Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown
AXGN Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
AXGN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
AXGN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by AXGN's directors and management

Government lobbying spending instances

  • $15,000 Feb 04, 2025 Issue: Health Issues
  • $10,000 Nov 06, 2024 Issue: Health Issues
  • $10,000 Aug 08, 2024 Issue: Health Issues
  • $10,000 May 06, 2024 Issue: Health Issues
  • $10,000 Feb 05, 2024 Issue: Health Issues
  • $10,000 Nov 14, 2023 Issue: Health Issues
  • $10,000 Aug 07, 2023 Issue: Health Issues
  • $10,000 Feb 09, 2023 Issue: Health Issues
  • $10,000 Nov 06, 2022 Issue: Health Issues
  • $10,000 Jul 18, 2022 Issue: Health Issues
  • $10,000 May 25, 2022 Issue: Health Issues
  • $30,000 Jan 19, 2011 Issue: Medical/Disease Research/Clinical Labs
  • $36,000 Oct 16, 2010 Issue: Medical/Disease Research/Clinical Labs
  • $36,000 Jul 14, 2010 Issue: Medical/Disease Research/Clinical Labs
  • $12,000 Apr 18, 2010 Issue: Medical/Disease Research/Clinical Labs

Estimated quarterly lobbying spending

AXGN Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
AXGN Income Statement
AXGN Balance Sheet
AXGN Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Connector and wrap for end-to-side nerve coaptation Feb. 25, 2025
  • Patent Title: Tissue-processing container for automated processing of tissue, methods of use thereof, and systems comprising the same Feb. 04, 2025
  • Patent Title: Packaging for wet tissue storage Dec. 10, 2024
  • Patent Title: Wet preservation of tissue Dec. 03, 2024
  • Patent Title: Fasciculated nerve grafts, methods of making the same, and methods of treatment using the same Jun. 04, 2024
  • Patent Title: Tissue grafts with pre-made attachment points May. 14, 2024
  • Patent Title: Organotypic drg-peripheral nerve culture system Apr. 16, 2024
  • Patent Title: Tissue-processing container for automated processing of tissue, methods of use thereof, and systems comprising the same Mar. 19, 2024
  • Patent Title: Organotypic drg-peripheral nerve culture system Jan. 30, 2024
  • Patent Title: Quantitative structural assay of a nerve graft Dec. 19, 2023
  • Patent Title: Wet preservation of tissue Aug. 29, 2023
  • Patent Title: Implant devices with a pre-set pulley system Feb. 28, 2023
  • Patent Title: Amnion tissue grafts and methods of preparing and using same Feb. 14, 2023
  • Patent Title: Wet preservation of tissue Dec. 13, 2022
  • Patent Title: Nerve culture system Nov. 29, 2022
  • Patent Title: Capture-tool for manipulating and entubulating nerves Jul. 12, 2022
  • Patent Title: Tissue grafts with pre-made attachment points Nov. 09, 2021
  • Patent Title: Organotypic drg-peripheral nerve culture system Oct. 26, 2021
  • Patent Title: Devices and methods for protecting against neuromas Oct. 19, 2021
  • Patent Title: Materials and methods for nerve repair with animal-sourced grafts Oct. 19, 2021
  • Patent Title: Materials and methods for protecting against neuromas Mar. 23, 2021
  • Patent Title: Materials and methods for protecting against neuromas Mar. 16, 2021
  • Patent Title: Implant devices with a pre-set pulley system Mar. 16, 2021
  • Patent Title: Connector and wrap for end-to-side nerve coaptation Nov. 17, 2020
  • Patent Title: Materials and methods for breast neurotization with nerve grafts Oct. 27, 2020
  • Patent Title: Quantitative structural assay of a nerve graft Sep. 22, 2020
  • Patent Title: Surgical tool for tissue sizing and transection Oct. 15, 2019
  • Patent Title: Capture-tool for manipulating and entubulating nerves Jul. 09, 2019
  • Patent Title: Quantitative structural assay of a nerve graft Jun. 04, 2019
  • Patent Title: Quantitative structural assay of a nerve graft Jun. 12, 2018
  • Patent Title: Quantitative structural assay of a nerve graft Jun. 27, 2017
  • Patent Title: Materials and methods for protecting against neuromas Apr. 25, 2017
  • Patent Title: Two-point discriminator sensory measurement device Jan. 31, 2017
  • Patent Title: Nerve elevator and method of use Oct. 01, 2013
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
AXGN News

Recent insights relating to AXGN

WallStreetBets

Number of mentions of AXGN in WallStreetBets Daily Discussion

CNBC Recommendations

Recent picks made for AXGN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AXGN

AXGN Analyst Ratings

AXGN Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
AXGN Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $AXGN stock a Buy, Sell, or Hold?

  • What is the price target for $AXGN stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

AXGN Top Shareholders
Shareholder
Shares Held
AXGN Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $AXGN stock?

  • Who owns the most shares of $AXGN stock?

  • What funds own $AXGN stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

AXGN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view AXGN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top